BAYER METASYSTOX SYSTEMIC INSECTICIDE

Main information

  • Trade name:
  • BAYER METASYSTOX SYSTEMIC INSECTICIDE
  • Class:
  • AgChem
  • Medicine domain:
  • Plants
  • Medicine type:
  • Allopathic drug

Documents

Localization

  • Available in:
  • BAYER METASYSTOX SYSTEMIC INSECTICIDE
    Australia
  • Language:
  • English

Therapeutic information

  • Therapeutic group:
  • APPLE CROP = APPLE ORCHARD | CANOLA OILSEED CROP | CEREAL CROP | CHOU MOELLIER | CHRYSANTHEMUM OR TANACETUM | CLOVER PASTURE | C
  • Therapeutic area:
  • INSECTICIDE
  • Therapeutic indications:
  • APHID | BLUEGREEN APHID | CABBAGE APHID | GENERAL WEED - SEE LABEL | GROUPED ORCHARD MITE | LEAF AND BUD NEMATODE | LUCERNE FLEA | MITE | PEA APHID | REDLEGGED EARTH MITE | SPOTTED ALFALFA APHID | TOMATO RUSSET MITE | TURNIP APHID | WOOLLY APHID | BARNYARD GRASS | BLADY GRASS | BROME GRASS | BUFFALO GRASS | CLOVER SPRINGTAIL | COUCH GRASS | DANDELION | FLATWEED | GREY CABBAGE APHID | GUINEA GRASS | KIKUYU GRASS | LANTANA | LIPAPHIS PSUEDOBRASSICAE | NUTGRASS | ONION WEED | OXALIS | PASPALUM | RED LEGGED EARTH MITE | RHODES GRASS | RYEGRASS | SORREL | SPIDER MITE | ST JOHN'S WORT | THERIOAPHIS TRIFOLII | TOMATO MITE (47236) | WEED CONTROL - GENERAL | WINTER GRASS

Other information

Status

  • Source:
  • Australian Pesticides and Veterinary Medicines Authority (APVMA)
  • Authorization status:
  • Archived
  • Authorization number:
  • 32913
  • Last update:
  • 09-08-2016

7-12-2018


Orphan designation: (1'R,6'R)-3-(benzylamine)-6-hydroxy-3'-methyl-4-pentyl-6'-(prop-1-en-2-yl)-[1,1'-bi(cyclohexane)]-2',3,6-triene-2,5-dione, Treatment of systemic sclerosis, 12/10/2017, Positive

Orphan designation: (1'R,6'R)-3-(benzylamine)-6-hydroxy-3'-methyl-4-pentyl-6'-(prop-1-en-2-yl)-[1,1'-bi(cyclohexane)]-2',3,6-triene-2,5-dione, Treatment of systemic sclerosis, 12/10/2017, Positive

Orphan designation: (1'R,6'R)-3-(benzylamine)-6-hydroxy-3'-methyl-4-pentyl-6'-(prop-1-en-2-yl)-[1,1'-bi(cyclohexane)]-2',3,6-triene-2,5-dione, Treatment of systemic sclerosis, 12/10/2017, Positive

Europe - EMA - European Medicines Agency